The DOI matches its Crossref record; 363 of the 375 references it cites were found in a registry or an index.
Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex
Abstract
Androgens, acting through the androgen receptor (AR), are responsible for the development of the male phenotype during embryogenesis, the achievement of sexual maturation at puberty, and the maintenance of male reproductive function and behavior in adulthood. In addition, androgens affect a wide variety of nonreproductive tissues. Moreover, aberrant androgen action plays a critical role in multiple pathologies, including prostate cancer and androgen insensitivity syndromes. The formation of a productive AR transcriptional complex requires the functional and structural interaction of the AR with its coregulators. In the last decade, an overwhelming and ever increasing number of proteins have been proposed to possess AR coactivating or corepressing characteristics. Intriguingly, a vast diversity of functions has been ascribed to these proteins, indicating that a multitude of cellular functions and signals converge on the AR to regulate its function. The current review aims to provide an overview of the AR coregulator proteins identified to date and to propose a classification of these AR coregulator proteins according to the function(s) ascribed to them. Taken together, this approach will increase our understanding of the cellular pathways that converge on the AR to ensure an appropriate transcriptional response to androgens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Androgen receptors can be modulated by specific proteins called coregulators [70–72] or mediated via the activation of membrane-bound protein receptors to initiate intracellular signalling pathways [73], which can occur even in the presence of low levels of androgens [74].”
From Integrating Transwomen and Female Athletes with Differences of Sex Development (DSD) into Elite Competition: The FIMS 2021 Consensus Statement (2021) · cites this paper as [71]
Citations
Cites
The Role of Chromatin during Transcription
Li, B., Carey, M., & Workman, J. L. (2007) · Cell · doi:10.1016/j.cell.2007.01.015 · Cited by 3,503
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M., & O’Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,887
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. L., Wilson, E. M., Lubahn, D. B., Harding, A., & Fischbeck, K. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,801
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
Oñate, S. A., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (1995) · Science · doi:10.1126/science.270.5240.1354 · Cited by 2,398
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription
Metzger, E., Wissmann, M., Yin, N., Müller, J. M., Schneider, R., Peters, A. H. F. M., Günther, T., Buettner, R., & Schüle, R. (2005) · Nature · doi:10.1038/nature04020 · Cited by 1,780
Androgen Receptor Defects: Historical, Clinical, and Molecular Perspectives*
Quigley, C. A., Bellis, A. D., Marschke, K. B., Awady, M. K. E., Wilson, E. M., & French, F. S. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-271 · Cited by 1,459
Proteasome-Independent Functions of Ubiquitin in Endocytosis and Signaling
Mukhopadhyay, D., & Riezman, H. (2007) · Science · doi:10.1126/science.1127085 · Cited by 1,221
Regulation of Transcription by a Protein Methyltransferase
Chen, D., Ma, H., Hong, H., Koh, S. S., Huang, S., Schurter, B. T., Aswad, D. W., & Stallcup, M. R. (1999) · Science · doi:10.1126/science.284.5423.2174 · Cited by 1,214
Steroid 5α-reductase: two genes/two enzymes
Russell, D. W., & Wilson, J. D. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.000325 · Cited by 1,105
Flagged first, then by citations
12 of the 375 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Litvinov, 2003, Is the Achilles’ heel for prostate cancer therapy a gain of function in androgen receptor signaling?, J Clin Endocrinol Metab, 88, 2972, 10.1210/jc.2002-022038 · DOI
Cited by
Sorted by citations
Items 501–600 of 753
Expression and regulation of aldehyde dehydrogenases in prostate cancer
Ibrahim, A. I. M., Sadiq, M., Frame, F. M., Maitland, N. J., & Pors, K. (2018) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.07 · Cited by 9
Tanase‐Nakao, K., Mizuno, K., Hayashi, Y., Kojima, Y., Hara, M., Matsumoto, K., Matsubara, Y., Igarashi, M., Miyado, M., & Fukami, M. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0494 · Cited by 9
Tang, T., Jiao, J., Li, D., Sun, G., Lin, L., Wang, C., Wang, S., Zou, R., Liu, W., Zhao, Y., et al. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111228 · Cited by 9
Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors
Radaeva, M., Li, H., Leblanc, E., Dalal, K., Ban, F., Ciesielski, F., Chow, B., Morin, H., Awrey, S. J., Singh, K., et al. (2022) · Cells · doi:10.3390/cells11182785 · Cited by 10
Varışlı, L., Tolan, V., CEN, J. H., Vlahopoulos, S., & Çen, O. (2022) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2022.026074 · Cited by 10
Hsiao, J. J., Ng, B. H., Smits, M. M., Martinez, H. D., Jasavala, R. J., Hinkson, I. V., Fermin, D., Eng, J. K., Nesvizhskii, A. I., & Wright, M. E. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1021 · Cited by 8
Leach, D. A., Chatterjee, N., Spahr, K., de Almeida, G. S., Varela‐Carver, A., Shah, T. T., Winkler, M. H., Ahmed, H. U., & Bevan, C. L. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70065 · Cited by 8
Ye, G. H., Zhang, Y., He, M.-L., Yu, M.-Q., Li, S.-R., Du, B.-Q., Gao, Y., Gao, Y., & Ye, X. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117937 · Cited by 10
Zhu, H., Yao, H., Xu, Y., Chen, Y., Han, B., Wang, N., Wang, H., Zhang, Q., Zhu, W., Shi, Y., et al. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01765-w · Cited by 8
Molecular effects of supraphysiological doses of doping agents on health
Imperlini, E., Mancini, A., Alfieri, A., Martone, D., Caterino, M., Orrù, S., & Buono, P. (2015) · Molecular BioSystems · doi:10.1039/c5mb00030k · Cited by 7
Mechanism underlying the retarded nuclear translocation of androgen receptor splice variants
Liu, Y., Wang, Y., Wang, F., Pan, J., Xu, J.-J., Li, J., Zhou, C., Ding, G., Wu, Y., Liu, X., et al. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9379-x · Cited by 8
A classification of genes involved in normal and delayed male puberty
Akram, M., Rizvi, S. S. R., Qayyum, M., & Handelsman, D. J. (2022) · Asian Journal of Andrology · doi:10.4103/aja202210 · Cited by 8
Future Developments in Osteoporosis Therapy
Ng, K. W. (2009) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153009789839192 · Cited by 8
Sideris, S., Aoun, F. Y., Martinez, C. N., Latifyan, S., Awada, A. H., Costante, G., & Gil, T. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0430-z · Cited by 8
den Broeck, T. V., Soebadi, M. A., Falter, A., Raets, L., Duponselle, J., Lootsma, J., Heintz, A., Philtjens, U., Hofkens, L., Viedma, A. G., et al. (2019) · Sexual Medicine · doi:10.1016/j.esxm.2019.10.003 · Cited by 10
Differential Roles of Androgen Receptor in Prostate Development and Cancer Progression
Yeh, S., Niu, Y., Miyamoto, H., Chang, T., & Chang, C. (2009) · Springer eBooks · doi:10.1007/978-0-387-69179-4_3 · Cited by 8
Inhibitors of the Transactivation Domain of Androgen Receptor as a Therapy for Prostate Cancer
Obst, J. K., Tien, A. H., Setiawan, J., Deneault, L. F., & Sadar, M. D. (2024) · Steroids · doi:10.1016/j.steroids.2024.109482 · Cited by 7
Sexual Dimorphism and Hypothalamic Astrocytes: Focus on Glioprotection
Thomaz, N. K., Bobermin, L. D., & Quincozes‐Santos, A. (2024) · Neuroglia · doi:10.3390/neuroglia5030019 · Cited by 7
Natural extranuclear androgen receptor ligands as endocrine disruptors of cancer cell growth
Kampa, M., Notas, G., & Castanas, E. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.021 · Cited by 7
Nuclear βArrestin1 regulates androgen receptor function in castration resistant prostate cancer
Purayil, H. T., Zhang, Y., Black, J. B., Gharaibeh, R. Z., & Daaka, Y. (2021) · Oncogene · doi:10.1038/s41388-021-01730-8 · Cited by 8
Bharati, J., Kumar, S., kumar, S., V, Mohan, N. H., Islam, R., Pegu, S. R., Banik, S., Das, B. C., Borah, S. R., & Sarkar, M. (2022) · Animal Biotechnology · doi:10.1080/10495398.2022.2079517 · Cited by 7
Şener, E. F., Dana, H., Tahtasakal, R., Hamurcu, Z., Taheri, S., Delibaşı, N., Mehmetbeyoğlu, E., Şükranlı, Z. Y., Dal, F., Tufan, E., et al. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110764 · Cited by 7
Modena, A., Ciccarese, C., Fantinel, E., Bimbatti, D., Tortora, G., & Massari, F. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.1063423 · Cited by 7
The hurdle of antiandrogen drug resistance: drug design strategies
Trendel, J. A. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.855194 · Cited by 7
Fiamegos, A., Varkarakis, J. M., Kontraros, M., Karagiannis, A., Chrisofos, M., Barbalias, D., & Deliveliotis, C. N. (2016) · International braz j urol · doi:10.1590/s1677-5538.ibju.2015.0167 · Cited by 7
Epigenetic Coregulation of Androgen Receptor Signaling
Fernandes, R. C., Leach, D. A., & Bevan, C. L. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11836-4_16 · Cited by 7
Male Sex Hormones, Analogs, and Antagonists
Brueggemeier, R. W. (2003) · Wiley eBooks · doi:10.1002/0471266949.bmc055 · Cited by 7
Reproductive and Nonreproductive Actions of Testosterone
Bhasin, S., & Jasuja, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65412-0 · Cited by 7
QSPRmodeler - An open source application for molecular predictive analytics
Bachorz, R. A., Nowak, D., & Ratajewski, M. (2024) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2024.1441024 · Cited by 6
Geng, H., Tang, D., Li, K., Xu, C., Wang, C., Zhang, X., He, X., & Cao, Y. (2024) · BMC Medical Genomics · doi:10.1186/s12920-024-01990-9 · Cited by 6
Androgen Receptors in Human Breast Cancer and Female Canine Mammary Tumors
Vidović, V., Davidov, I., Ružić, Z. N., Erdeljan, M., Galfi, A., & Blagojević, B. (2025) · Molecules · doi:10.3390/molecules30071411 · Cited by 6
Shuai, Y., & Huang, H. (2025) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2025.06.001 · Cited by 6
Lin, J., Zhu, J., Fowke, J. H., Narayanan, R., & Liu, F. (2025) · Cancers · doi:10.3390/cancers17213414 · Cited by 7
Phase Separation Mediated Sub-Nuclear Compartmentalization of Androgen Receptors
Yavuz, S., Abraham, T. E., Houtsmuller, A. B., & van Royen, M. E. (2024) · Cells · doi:10.3390/cells13201693 · Cited by 6
Malcher, A., Jędrzejczak, P., Stokowy, T., Monem, S., Nowicka-Bauer, K., Zimna, A., Czyzyk, A., Maciejewska-Jeske, M., Męczekalski, B., Bednarek-Rajewska, K., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215418 · Cited by 6
Stefano, R. F. D., Tucci, M., Turco, F., Samuelly, A., Bungaro, M., Pisano, C., Vignani, F., Gallicchio, M., Scagliotti, G. V., Maïo, M. D., et al. (2021) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-021-00336-1 · Cited by 6
Du, P., Li, G., Zhu, J., Luo, Y., Fu, N., & Li, Y. (2021) · Journal of Genetics · doi:10.1007/s12041-021-01269-3 · Cited by 6
Chauhan, G., & Heemers, H. V. (2021) · Cancers · doi:10.3390/cancers13163947 · Cited by 6
Self-citationSecondary Cancer after Androgen Deprivation Therapy in Prostate Cancer: A Nationwide Study
Kim, J. H., Bae, G. H., Jung, J., & Noh, T. I. (2024) · The World Journal of Men s Health · doi:10.5534/wjmh.230237 · Cited by 6
Identification of NR0B1 as a novel androgen receptor co-repressor in mouse Sertoli cells
Li, Y., Luo, M.-L., Guo, H., Wang, T.-T., Lin, S.-R., Chen, J.-B., Ma, Q., Gu, Y.-L., Jiang, Z.-M., & Gui, Y. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2672 · Cited by 6
Obeidat, F. N., Ahram, M. A., Khader, A. A., Mbaideen, S. A., Hassan, H., Al-Tarawneh, B., & Battah, K. (2018) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2018.326 · Cited by 6
Impact of Benzimidazole Containing Scaffolds as Anticancer Agents through Diverse Modes of Action
Sharma, S., Gupta, M., Gupta, M., & Sahu, J. K. (2023) · Current Bioactive Compounds · doi:10.2174/1573407219666230406082148 · Cited by 6
Austin, R. J., Smidansky, H. M., Holstein, C. A., Chang, D. K., Epp, A., Josephson, N. C., & Martin, D. B. (2011) · PROTEOMICS · doi:10.1002/pmic.201100348 · Cited by 6
Acute Exercise and Cognition in Children and Adolescents
Koutsandréou, F., Niemann, C., Wegner, M., & Budde, H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800778-5.00013-x · Cited by 7
Manning, J. T., & Fink, B. (2018) · Springer eBooks · doi:10.1007/978-3-319-16999-6_3829-1 · Cited by 6
Song, Y., Zhang, K., Zhang, J., Li, Q., Huang, N., Ma, Y., Hou, N., Han, F., Kan, C., & Sun, X. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101481 · Cited by 7
Tanio, M., Miyamoto, Y., Saka, T., Kudo, Y., Hayashi, R., Kawano, S., Yoshino, Y., Abe, N., Yamaguchi, E., Arai, Y., et al. (2025) · Steroids · doi:10.1016/j.steroids.2025.109692 · Cited by 6
Ye, C., Ma, Y., Shrestha, R., Cai, J., Liu, Y., Peng, L., Yu, J., & Cai, H. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.09.045 · Cited by 6
Miyoshi, K., Yamaguchi, T., Fujikura, Y., Kazeto, Y., Okuzawa, K., & Uji, S. (2025) · Fisheries Science · doi:10.1007/s12562-025-01856-8 · Cited by 5
Modi, P. K., Faiena, I., & Kim, I. Y. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800077-9.00003-7 · Cited by 5
The MYH9 Cytoskeletal Protein Is a Novel Corepressor of Androgen Receptors
Liu, C., Liao, Z., Duan, X., Pan, Y., Kong, P., Tao, Z., & Liu, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.641496 · Cited by 5
Role of CAG and GGC Polymorphism of the Androgen Receptor Gene in Male Fertility
Осадчук, Л. В., & Осадчук, А. В. (2022) · Russian Journal of Genetics · doi:10.1134/s1022795422020119 · Cited by 6
The Effect of AR Overexpression on Androgen Signaling in Prostate Cancer
Urbanucci, A., Waltering, K. K., Mills, I. G., & Visakorpi, T. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6182-1_12 · Cited by 5
ANDROGEN RECEPTOR CAG AND GGN REPEAT POLYMORPHISMS AND BONE MASS IN BOYS AND GIRLS.
Rodríguez‐García, L., Ponce‐González, J. G., González, J. J., Rodríguez-González, F. G., Díaz-Chico, B. N., Calbet, J. A. L., Serrano, J. A., Dorado, C., & Guadalupe‐Grau, A. (2015) · PubMed · doi:10.3305/nh.2015.32.6.9767 · Cited by 5
The Biological Role of Androgen Receptor in Prostate Cancer Progression
Takayama, K. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.76360 · Cited by 5
Peripheral Sensitivity to Steroids Revisited
Hampl, R., & Vondra, K. (2017) · Physiological Research · doi:10.33549/physiolres.933725 · Cited by 5
Dalton, J. T., & Gao, W. (2010) · Springer eBooks · doi:10.1007/978-90-481-3303-1_6 · Cited by 5
SWI/SNF chromatin remodelers in prostate cancer progression
Ordonez‐Rubiano, S. C., Strohmier, B. P., Sood, S., & Dykhuizen, E. C. (2024) · Frontiers in Epigenetics and Epigenomics · doi:10.3389/freae.2023.1337345 · Cited by 5
Busillo, J. M., Rhen, T., & Cidlowski, J. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00005-6 · Cited by 5
Sutinen, P., Malinen, M., & Palvimo, J. J. (2017) · Endocrinology · doi:10.1007/978-3-319-44441-3_12 · Cited by 5
Melnik, B. C. (2014) · Springer eBooks · doi:10.1007/978-3-540-69375-8_14 · Cited by 5
Molecular biology of castration-resistant prostate cancer: basis for the novel therapeutic targets.
Mellado, B., Marín‐Aguilera, M., & Pereira, M. V. (2013) · PubMed · Cited by 5
Geng, Q., Ni, L.-W., Ouyang, B., Hu, Y., Zhao, Y., & Guo, J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6028 · Cited by 5
Parsons, T. K., Pratt, R. N., Tang, L., & Wu, Y. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.06.009 · Cited by 5
Forootan, S. S., Hussain, S. A., Aachi, V., Foster, C. S., & Ke, Y. (2014) · Journal of Andrology and Gynaecology · doi:10.13188/2332-3442.1000017 · Cited by 5
Villeneuve, D. L. (2018) · OECD series on adverse outcome pathways · doi:10.1787/b0c6838a-en · Cited by 5
Svingen, T., Elmelund, E., Holmer, M. L., Bindel, A. O., Holbech, H., & Draskau, M. K. (2025) · Environmental Toxicology and Chemistry · doi:10.1093/etojnl/vgaf221 · Cited by 4
Rollin, S., Lawrence, M. G., Joshua, A. M., & Selth, L. A. (2024) · Endocrine Related Cancer · doi:10.1530/erc-24-0208 · Cited by 4
Transcriptional regulation of PEBP1 expression by androgen receptor in mouse testes
Deng, Q., Wang, Z., Du, Y., Zhang, Y., & Liang, H. (2021) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2021.2004471 · Cited by 4
Androgen Regulation of Neural Circuit Activity: Molecules and Mechanisms
Durdiaková, J., & Celec, P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00047-x · Cited by 4
Farag, A. G. A., Shoiab, M. A., Samaka, R. M., Abdou, A. G., Elnaidany, N. F., & Mansour, A. O. M. (2019) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/ijdvl.ijdvl_35_18 · Cited by 4
AL-Eitan, L. N., Alghamdi, M. A., Tarkhan, A. H., & Al‐Qarqaz, F. (2019) · Genes · doi:10.3390/genes11010034 · Cited by 4
The androgen receptor for the radiation oncologist
Quéro, L., Rozet, F., Beuzeboc, P., & Hennequin, C. (2015) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2015.02.008 · Cited by 5
Androgen Receptor Gene Rearrangements: New Perspectives on Prostate Cancer Progression
Brand, L. J., & Dehm, S. M. (2013) · Current Drug Targets · doi:10.2174/13894501113149990151 · Cited by 4
GENETIC VARIABILITY IN THE PRNCR1 GENE AMONG A SAMPLE OF IRAQI PROSTATE CANCER PATIENTS
Kadhim, R. I., & Salman, E. D. (2022) · IRAQI JOURNAL OF AGRICULTURAL SCIENCES · doi:10.36103/ijas.v53i3.1559 · Cited by 3
Gür, M., Dil, E., Akdeniz, E., Çobanoğlu, Ü., Kalyoncu, N. İ., Topbaş, M., & Özyavuz, R. (2024) · New Trends in Medicine Sciences · doi:10.56766/ntms.1441182 · Cited by 3
The Role of Androgen-Regulated Long Noncoding RNAs in Prostate Cancer
Takayama, K., & Inoue, S. (2015) · Springer eBooks · doi:10.1007/978-4-431-55576-6_11 · Cited by 3
Nuclear Receptor Coregulators: Promising Therapeutic Targets for the Treatment of Prostate Cancer
Heemers, H. V., & Tindall, D. J. (2010) · Springer eBooks · doi:10.1007/978-1-60327-829-4_3 · Cited by 3
Self-citationChen, X., Xu, C., Wang, X., Yao, Y., Wu, G., & Wu, D. (2022) · Research Square · doi:10.21203/rs.3.rs-1263609/v1 · Cited by 4
Influence of radical prostatectomy on miRNA dynamics in urine extracellular vesicles
Shutko, E. V., Bryzgunova, O. E., Murina, E. A., Ostaltcev, I. A., Krasilnikov, S. E., Laktionov, P. P., & Konoshenko, M. Y. (2024) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2024.06.017 · Cited by 3
Truncated Androgen Receptor Splice Variants in Prostate Cancer
Lonergan, P. E., & Tindall, D. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6828-8_13 · Cited by 3
Self-citationAndrogen Receptor in Health and Disease
Marcelli, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_2 · Cited by 3
NPM : un nouvel acteur dans le cancer de la prostate ?
Beaudoin, C., Maquaire, S., Léotoing, L., Allemand, J., Lours-Calet, C., VEYSSIERE, G., Manin, M., & Morel, L. (2009) · médecine/sciences · doi:10.1051/medsci/200925119 · Cited by 3
Human CMTM2/CKLFSF2 enhances the ligand-induced transactivation of the androgen receptor
Liu, D., Yin, C., Zhang, Y., Tian, L., Li, T., Li, D., Ma, D., Guo, Y., & Wang, Y. (2009) · 中国科学通报:英文版 · doi:10.1007/s11434-009-0092-8 · Cited by 3
A Clinical Metabolomics Strategy to Discover New Biomarkers in Complex Disease: An Overview
Baumgärtner, C. (2013) · Biomedizinische Technik/Biomedical Engineering · doi:10.1515/bmt-2013-4305 · Cited by 3
Role of FKBP51 and FKBP52 in glucocorticoid receptor regulated metabolism
Warrier, M. (2008) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 3
Martin, S. K., Fiandalo, M. V., & Kyprianou, N. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6182-1_15 · Cited by 3
2D:4D indicates phimosis risk: A study on digit ratio and early foreskin development
Li, G., Huo, Y., Sun, K., Wang, X., Li, H., Gao, L., & Ma, B. (2016) · Early Human Development · doi:10.1016/j.earlhumdev.2016.05.013 · Cited by 3
Paliouras, M., Alvarado, C., & Trifiro, M. A. (2016) · InTech eBooks · doi:10.5772/64392 · Cited by 3
Liu, X. Y., Cai, Z., Li, F., & Ji, L. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2018.1554634 · Cited by 3
Obesity and aggressive prostate cancer
Lehrer, S. P. (2020) · Cancer · doi:10.1002/cncr.32761 · Cited by 3
CAGn Polymorphic Locus of Androgen Receptor (AR) Gene in Russian Infertile and Fertile Men
Chernykh, V. B., Solovova, O., Sorokina, T., Штаут, М. И., Седова, А. О., Bliznetz, E. A., Ismagilova, O. R., Beskorovainaya, T. S., Shchagina, O., & Polyakov, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212183 · Cited by 2
Fu, X., Zhang, Z., Chen, R., Jun, A., An, N., Tian, X., & Dong, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-05659-w · Cited by 2
Xu, H., Zhang, H., Yang, R., Xie, X., Cao, Z., Zhao, Y. (., Lin, H., Lu, D., Bischoff, F. Z., Zhang, X., et al. (2026) · The Innovation Nutrition · doi:10.59717/j.xinn-nutri.2026.100004 · Cited by 2
Mercinelli, C., Costanzo, F. D., Oing, C., Guandalini, G., Maiorano, B. A., Sammarco, E., Salfi, A., Serafin, D., Tateo, V., Cigliola, A., et al. (2026) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2026.2695214 · Cited by 2
Long, W., & O’Malley, B. W. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-8039-6_1 · Cited by 2
El-taher, E. T., Zamzam, M. L., Elzawawy, A. M., Hassan, W. A., & Suliman, M. A. (2020) · Journal of Solid Tumors · doi:10.5430/jst.v10n2p22 · Cited by 2
Androgen receptor-dependent mechanisms mediating therapy resistance in prostate cancer
Saker, Z., Rizk, M., & Nabha, S. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-16032-5.00004-x · Cited by 2
Potential roles of FGF5 as a candidate therapeutic target in prostate cancer.
Stangis, M. M., Colah, A. N., McLean, D. T., Halberg, R. B., Collier, L. S., & Ricke, W. A. (2023) · PubMed Central · Cited by 2
Chaturvedi, G., Sarusi-Portuguez, A., Loza, O., Shimoni-Sebag, A., Yoron, O., Lawrence, Y. R., Zach, L., & Hakim, O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020970 · Cited by 2
Metadata
- Authors
- Heemers, H. V., & Tindall, D. J.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Tindall, Donald J.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2007-10-16
- Volume
- 28
- Issue
- 7
- Pages
- 778-808
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2164092182
- Cited by
- 753
- References
- 375
- Citations by year
- 2026: 12 · 2025: 26 · 2024: 30 · 2023: 29 · 2022: 40 · 2021: 48 · 2020: 26 · 2019: 37 · 2018: 37 · 2017: 38 · 2016: 54 · 2015: 49 · 2014: 42 · 2013: 70 · 2012: 52
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA121277, CA125747, R01CA125747, CA 91956, CA121277, P50CA091956, CA 15083, P30CA015083)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK065236, DK65236)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- androgen receptor, coregulators, transcriptional coactivator, corepressors, transcriptional complex, androgen signaling, male reproductive development, prostate cancer, androgen insensitivity syndrome
- MeSH terms
- Androgens, Gene Expression Regulation, Humans, Male, Receptors, Androgen, Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review